These data suggest that the robust Tfh, pre-Tfh, and GC B cell responses were resulted from both immune-modulation and ZIKV infection, but not caused by treatment with the anti-IFNAR1 antibody alone. Here, IFNAR1 is linked to Zika virus infectious disease.